Wei Wen

3.8k total citations
76 papers, 2.0k citations indexed

About

Wei Wen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wei Wen has authored 76 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 28 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Wei Wen's work include Cancer Genomics and Diagnostics (9 papers), Cancer Mechanisms and Therapy (8 papers) and Cytokine Signaling Pathways and Interactions (7 papers). Wei Wen is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Cancer Mechanisms and Therapy (8 papers) and Cytokine Signaling Pathways and Interactions (7 papers). Wei Wen collaborates with scholars based in United States, China and United Kingdom. Wei Wen's co-authors include Thanh H. Dellinger, Marsha A. Moses, Dmitri Wiederschain, Jack L. Arbiser, Ernest Han, Chee‐Onn Leong, John H. Yim, Richard Jove, Yiran Chen and Carlotta A. Glackin and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Wei Wen

74 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Wen United States 27 991 551 469 193 179 76 2.0k
Zhengjie Huang China 25 887 0.9× 460 0.8× 507 1.1× 153 0.8× 113 0.6× 90 2.3k
Yong Wan China 30 1.7k 1.8× 439 0.8× 636 1.4× 180 0.9× 98 0.5× 74 2.6k
José A. Seoane Spain 21 839 0.8× 396 0.7× 372 0.8× 161 0.8× 80 0.4× 55 1.6k
Emiel A. M. Janssen Norway 26 833 0.8× 583 1.1× 571 1.2× 169 0.9× 180 1.0× 107 2.1k
Lina Yang China 25 1.0k 1.1× 533 1.0× 383 0.8× 163 0.8× 155 0.9× 113 2.2k
Xiaoqing Yang China 34 1.8k 1.8× 666 1.2× 506 1.1× 291 1.5× 152 0.8× 136 3.2k
Zhi-Hua Zhou China 27 660 0.7× 596 1.1× 361 0.8× 157 0.8× 73 0.4× 63 2.0k
Piyushkumar A. Mundra Australia 20 745 0.8× 362 0.7× 260 0.6× 112 0.6× 63 0.4× 48 1.6k
Guanzhen Yu China 27 1.5k 1.6× 532 1.0× 763 1.6× 341 1.8× 165 0.9× 81 2.3k

Countries citing papers authored by Wei Wen

Since Specialization
Citations

This map shows the geographic impact of Wei Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wen more than expected).

Fields of papers citing papers by Wei Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wen. The network helps show where Wei Wen may publish in the future.

Co-authorship network of co-authors of Wei Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Wen. A scholar is included among the top collaborators of Wei Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Wen. Wei Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Wei, Adam J. Mead, & Supat Thongjuea. (2023). MARVEL: an integrated alternative splicing analysis platform for single-cell RNA sequencing data. Nucleic Acids Research. 51(5). e29–e29. 13 indexed citations
2.
Yan, Bing, et al.. (2022). Correlation and prognostic implications of intratumor and tumor draining lymph node Foxp3+ T regulatory cells in colorectal cancer. BMC Gastroenterology. 22(1). 122–122. 4 indexed citations
3.
Wen, Wei, et al.. (2021). Residue Specific Binding Mechanisms of PD-1 to Its Monoclonal Antibodies by Computational Alanine Scanning. Gaodeng xuexiao huaxue xuebao. 42(7). 2161. 1 indexed citations
4.
Roy, Anindita, Guanlin Wang, Deena Iskander, et al.. (2021). Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human development. Cell Reports. 36(11). 109698–109698. 34 indexed citations
5.
Wen, Wei, Adam J. Mead, & Supat Thongjuea. (2020). VALERIE: Visual-based inspection of alternative splicing events at single-cell resolution. PLoS Computational Biology. 16(9). e1008195–e1008195. 9 indexed citations
6.
Yang, Fengming, Chunfeng Pan, Xianglong Pan, et al.. (2020). Correction: miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC. Cell Death and Disease. 11(4). 5 indexed citations
8.
Wen, Wei, Ernest Han, Thanh H. Dellinger, et al.. (2019). Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer. Translational Oncology. 12(8). 1015–1025. 9 indexed citations
9.
Li, Jingmei, Wei Wen, Brennan Decker, et al.. (2018). Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer. Cancer Research. 78(21). 6329–6338. 16 indexed citations
10.
Wen, Wei, Yuxiong He, Samyam Rajbhandari, et al.. (2017). Learning Intrinsic Sparse Structures within Long Short-Term Memory. International Conference on Learning Representations. 14 indexed citations
11.
Park, Jongsoo, Wei Wen, Ping Tang, et al.. (2016). Faster CNNs with Direct Sparse Convolutions and Guided Pruning. International Conference on Learning Representations. 18 indexed citations
12.
Park, Jongsoo, et al.. (2016). Holistic SparseCNN: Forging the Trident of Accuracy, Speed, and Size. arXiv (Cornell University). 1. 11 indexed citations
13.
Roberts, Cai M., Sophia Allaf Shahin, Wei Wen, et al.. (2016). Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models. Nanomedicine Nanotechnology Biology and Medicine. 13(3). 965–976. 67 indexed citations
14.
Dellinger, Thanh H., et al.. (2016). Therapeutic potential of ruxolitinib in human ovarian cancer. Gynecologic Oncology. 141. 45–46. 1 indexed citations
15.
Hasmad, Hanis Nazihah, Wei Wen, Daniel J. Park, et al.. (2015). Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients. Gynecologic Oncology. 141(2). 318–322. 16 indexed citations
16.
Liu, Lucy, Yan Tian, Jun Wu, et al.. (2013). MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells. Cancer Biology & Therapy. 15(2). 178–184. 26 indexed citations
18.
Liang, Wei, Maciej Kujawski, Jun Wu, et al.. (2010). Antitumor Activity of Targeting Src Kinases in Endothelial and Myeloid Cell Compartments of the Tumor Microenvironment. Clinical Cancer Research. 16(3). 924–935. 51 indexed citations
19.
Zhang, Kuo, Lü Jin, Taizo Mori, et al.. (2010). Baicalin increases VEGF expression and angiogenesis by activating the ERR /PGC-1  pathway. Cardiovascular Research. 89(2). 426–435. 90 indexed citations
20.
Liang, Wei, Andreas Herrmann, Michael Hedvat, et al.. (2008). The Src family kinase inhibitor, dasatinib, inhibits angiogenesis in vitro and in vivo. Cancer Research. 68. 270–270. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026